🇿🇦 QSC Peptides South Africa  ·  Order from QSC →

Buy Tirzepatide in South Africa

International Shipping CAS 2023788-19-2  ·  GIP/GLP-1 Dual Agonist  ·  8–12 days  ·  >=99% purity

Tirzepatide is a dual GIP and GLP-1 receptor agonist. SURMOUNT-1 demonstrated 20.9% mean body weight reduction at 72 weeks — the largest in any Phase 3 obesity trial at time of publication. QSC ships internationally to South Africa in 8–12 business days. South Africa is Africa's premier biomedical research market — UCT, Wits, Stellenbosch, Aspen Pharmacare, and the world's largest ART programme all generate sophisticated research demand in GIP/GLP-1 Dual Agonist and related areas.

Tirzepatide (CAS 2023788-19-2): Tirzepatide (CAS 2023788-19-2, 39-amino acid peptide) activates both GIPR and GLP-1R simultaneously. Dual agonism produces additive insulin secretion, enhanced beta-cell function, and greater hypothalamic appetite suppression vs GLP-1 monotherapy. Half-life approximately 5 days. QSC supplies research-grade Tirzepatide at >=99% HPLC purity, Janoshik COA. Order at qscpeptide.com.

Buy Tirzepatide — International Shipping to South Africa

R1,147 / USD 62 · 8–12 business days · Free shipping · >=99% HPLC, Janoshik COA. Bitcoin and USDT.

Buy Tirzepatide at QSC →

South Africa Shipping Details

ProvinceDelivery Time
Gauteng (Johannesburg, Pretoria)8–12 business days
Western Cape (Cape Town, Stellenbosch)8–12 business days
KwaZulu-Natal (Durban)8–12 business days
Eastern Cape, Free State, Mpumalanga10–14 business days
Limpopo, North West, Northern Cape10–16 business days
Tracking numberAll orders
Shipping costFree
Purity>=99% HPLC
COAJanoshik (independent)
PaymentBitcoin / USDT
PricingZAR (R) and USD listed

Mechanism of Action

Tirzepatide (CAS 2023788-19-2, 39-amino acid peptide) activates both GIPR and GLP-1R simultaneously. Dual agonism produces additive insulin secretion, enhanced beta-cell function, and greater hypothalamic appetite suppression vs GLP-1 monotherapy. Half-life approximately 5 days.

Tirzepatide — Research Data

SURMOUNT-1 (NCT04184622): 20.9% weight reduction at 72 weeks. SURPASS-2 vs semaglutide: superior on both HbA1c and weight. South Africa has one of the highest rates of type 2 diabetes in sub-Saharan Africa — approximately 12.7% of adults (IDF 2024) — making dual incretin agonist research highly relevant to UCT, Wits, and UKZN clinical pharmacology programmes.

Available Nationwide

QSC ships Tirzepatide internationally to all 9 South African provinces: Gauteng (Johannesburg, Pretoria/Tshwane), Western Cape (Cape Town, Stellenbosch), KwaZulu-Natal (Durban), Eastern Cape (Gqeberha, East London), Free State (Bloemfontein), Mpumalanga, Limpopo, North West, and Northern Cape. Key institutions — UCT, Wits, Stellenbosch University, UP, SAMRC, Aspen Pharmacare, KBC facilities — all within the delivery network. ZAR (R) and USD pricing shown. Payment: Bitcoin (BTC) and USDT/USDC only.

Shipping InfoAll CompoundsSemaglutideTirzepatideEpitalonSS-31BPC-157

QSC Network

For Research Use Only. All compounds are exclusively for laboratory research. Not intended for human consumption. Shipped internationally by QSC.